MUC2 and colonic neoplasm: When evaluating new biomarkers for colon cancer, MUC1, MUC2, MUC4, MUC5AC, and MUC6 are currently documented in the largest bodies of work regarding their role in the progression from normal colonic tissue to malignancy.